SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: Grainne who wrote (1068)2/25/1998 6:04:00 PM
From: WeirdPro Randy  Read Replies (1) | Respond to of 1359
 
<My opinion is the result of conversations with a very limited number of neurologists familiar with the drug [i.e., the trials] who thing it is not better than sugar water.> While the study results totally contradicts this conclusion, I was amused by this statement and wondered if these same neurologists would abstain from the use of CerAxon (after it has been approved and becomes available), in lieu of the alternative which is to do nothing.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News